Get started
Author

Fernando Valdez‐Urias

Observed names: F. Valdez‐Urias, Fernando Valdez-Urias
ORCID: 0009-0004-7894-4973
Observed ORCID: 0009-0004-7894-4973
OpenAlex ID: A5010212065
Arginine vasopressin deficiency and conivaptan (a V1a–V2 receptor antagonist) treatment reverses liver damage and fibrosis in rats with chronic portocaval anastomosis
2023 · Yesenia Danyeli Navarro‐Gonzalez, Javier Ventura‐Juarez, et al. · International Journal of Experimental Pathology · 8
PDF
Arginine vasopressin hormone receptor antagonists in experimental autoimmune encephalomyelitis rodent models: A new approach for human multiple sclerosis treatment
2023 · Argelia Calvillo-Robledo, Cynthia Ramírez-Farías, et al. · Frontiers in Neuroscience · 7
PDF
Effects of Arginine Vasopressin (AVP) Deficiency, Conivaptan and Desmopressin on Clinical Symptoms and Blood Cytokine Levels in Rats with Experimental Autoimmune Encephalomyelitis
2018 · Andres Quintanar‐Stephano, Veronica Viñuela‐Berni, et al. · The FASEB Journal · 3
Effects of the Neurointermediate Pituitary Lobectomy (NIL) on Pituitary Hormones Blood Level in the Rat
2016 · Alejandro Organista‐Esparza, Verónica Viñuela‐Berni, et al. · The FASEB Journal · 3
Gene expression profile and cytokine analysis in experimental autoimmune encephalomyelitis (EAE) in AVP deficient rats
2019 · Andres Quintanar‐Stephano, Verónica Viñuela‐Berni, et al. · The FASEB Journal · 1
Long‐Term Hepatorenal Toxicity Assessment of the Vasopressin Receptor Antagonist Conivaptan in Lewis Rats: Implications for Therapeutic Safety
2026 · F. Valdez‐Urias, A. Calvillo Robledo, et al. · Journal of Applied Toxicology
Desmopressin inhibit the proliferation and cellular migration in the OV‐90 ovarian cancer cell line
2020 · Argelia Calvillo-Robledo, Zaira Samantha González-Sánchez, et al. · The FASEB Journal
Works count: 7
Citation count: 22
H-index: 3
I10-index:
Year
Topic
Type